July 28, 2025 - 12:51

OpenAI’s ChatGPT has ignited a transformative wave in artificial intelligence development and investment. However, a leading figure in the cloud and AI sector believes that a significant portion of the advancements and services that have emerged in the wake of this revolution may not withstand the test of time. According to the founder of Alibaba's cloud division, approximately 90% of the technologies and services launched since the rise of ChatGPT could potentially vanish within the next decade.
This assertion underscores the volatile nature of the AI industry, where rapid innovation often leads to fleeting trends. The founder expressed concerns that many current offerings may lack the foundational robustness needed for long-term sustainability. As the market continues to evolve, companies will need to focus on creating enduring solutions that address real-world challenges rather than merely riding the wave of hype. The future of AI will likely hinge on the ability to adapt and innovate beyond initial excitement.
October 28, 2026 - 23:36
CSX Works Through Tech Outage as Security Team Confirms No CyberattackCSX is working through a technology outage that began Tuesday, with the company`s security team confirming the disruption was not a cyberattack and that no data breach occurred, according to a...
October 28, 2026 - 06:35
The Human Side of Patient CRM Upgrades: Four Choices Tech Cannot SolveModernizing a patient relationship management system is often framed as a software problem, but the hardest parts are not technical. Jaymin Sutarwala of United Therapeutics argues that four key...
October 27, 2026 - 19:33
SPOOKY SPECTACULAR - GATEWAY HEADS-UP MAFIA 2026 GRAND FINALETwo days. More than 360 cars. Nearly $30,000 in payouts. One weekend that will not be forgotten anytime soon. Some races are good. Some are memorable. Then there are weekends that remind everyone...
October 27, 2026 - 00:50
Aptar Pharma Expands Pulmonary Delivery Capabilities with Pulmotree AcquisitionAptar Pharma, a division of AptarGroup Inc., has acquired Pulmotree, a life sciences company based in Munich, Germany. The move strengthens the company`s position in pulmonary drug delivery...